Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now?
On December 15, Immunome, Inc. (NASDAQ:IMNM) shared positive topline results from the Phase 3 RINGSIDE trial, demonstrating an improved survival rate without progression, when compared with a placebo.


